MedTrace Logo

Contrast Volume Reduction During PCI With the Use of a New Assisting Software Package

NCT02927990 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-12-06

Study results available
· View outcomes & findings →

Summary

The new software package is intended to assist the physician in imaging the coronaries during percutaneous coronary interventions.

This study investigates the amount of contrast used during percutaneous coronary interventions with the aid of the new software package.

The results of the study will be compared with control group data (before the new software package was installed or after it was removed) to define a possible contrast reduction.

Conditions

  • Coronary Stenosis
  • Coronary Occlusion

Interventions

OTHER

Percutaneous Coronary Intervention

Percutaneous Coronary Intervention according to standard of care

Sponsors & Collaborators

  • Philips Clinical & Medical Affairs Global

    lead INDUSTRY

Principal Investigators

  • Manish Parikh, MD · Columbia University Medical Center/NYPH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-15
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02927990 on ClinicalTrials.gov